Wednesday, July 8, 2026

Drug profile · INN

molindone hydrochloride

molindone hydrochloride (MOLINDONE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — molindone hydrochloride
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

molindone hydrochloride (MOLINDONE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN molindone hydrochloride
Brand MOLINDONE HYDROCHLORIDE
Mechanism Dopamine D2 receptor antagonist
Target D(2) dopamine receptor
Route ORAL
Formulation CAPSULE

Mechanism of action

Dopamine D2 receptor antagonist

Primary target: D(2) dopamine receptor

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Molindone Phase 2 · SUPERNUS PHARMACEUTICALS · Impulsive Aggression Comorbid With ADHD in Children

Related & competitor drugs

  1. aripiprazole Nervous system (N05)
  2. brexpiprazole Nervous system (N05)
  3. cabergoline Dopamine D2 receptor agonist
  4. clozapine Serotonin 2a (5-HT2a) receptor antagonist
  5. fluphenazine decanoate Dopamine D2 receptor antagonist
  6. fluphenazine hydrochloride Dopamine D2 receptor antagonist

Frequently asked questions

What is molindone hydrochloride?

molindone hydrochloride (MOLINDONE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for molindone hydrochloride?

MOLINDONE HYDROCHLORIDE is a marketed brand name for molindone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of molindone hydrochloride?

molindone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.